GlassScriptPhysician profile
Tom O Mcguire
NPI 1205812435
$1,107.05
in general payments reported to CMS, 2019-2025
22 companies · $320 in 2025
The $320 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.29 · 2021: $92.38 · 2022: $196 · 2023: $242 · 2024: $167 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $224.60 | 2021-2024 | Injectafer |
| Sage Therapeutics, LLC | $202.54 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $82.31 | 2019-2025 | |
| Pfizer INC. | $78.75 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $73.25 | 2023-2025 | |
| Exeltis, USA INC. | $64.98 | 2023-2025 | Slynd |
| Minerva Surgical, INC | $43.96 | 2019 | |
| Hologic Sales and Service, LLC | $33.54 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Astellas Pharma US INC | $31.59 | 2023-2024 | Veozah, Myrbetriq |
| Supernus Pharmaceuticals, INC. | $31.11 | 2025 | Qelbree |
| Gynesonics, INC. | $28.28 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Nestle Healthcare Nutrition INC. | $27.00 | 2022-2023 | |
| Meditrina | $25.71 | 2024-2025 | |
| Heron Therapeutics, INC. | $21.79 | 2023 | Aponvie |
| Davol INC. | $20.00 | 2023 | Arista Ah Flexitip |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $19.25 | 2024 | Axonics |
| Becton, Dickinson and Company | $18.71 | 2023 | Bd Surepath Collection Vial |
| Amag Pharmaceuticals, INC. | $18.57 | 2019 | |
| Eagle Pharmaceuticals, INC. | $16.83 | 2023 | |
| Urovant Sciences INC | $16.08 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.42 | 2023 | Gattex |
| Smith+Nephew, INC. | $12.78 | 2023 | Pico 7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Mcguire listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.